Intellia Therapeutics (NTLA) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Intellia Therapeutics (NTLA) over the last 10 years, with Q3 2025 value amounting to $2.9 million.
- Intellia Therapeutics' Other Non-Current Assets fell 972.14% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 972.14%. This contributed to the annual value of $3.8 million for FY2024, which is 1615.76% down from last year.
- Per Intellia Therapeutics' latest filing, its Other Non-Current Assets stood at $2.9 million for Q3 2025, which was down 972.14% from $3.6 million recorded in Q2 2025.
- In the past 5 years, Intellia Therapeutics' Other Non-Current Assets registered a high of $5.2 million during Q3 2021, and its lowest value of $2.9 million during Q3 2025.
- Moreover, its 4-year median value for Other Non-Current Assets was $3.8 million (2024), whereas its average is $3.9 million.
- In the last 5 years, Intellia Therapeutics' Other Non-Current Assets soared by 7722.28% in 2021 and then crashed by 2489.32% in 2025.
- Over the past 4 years, Intellia Therapeutics' Other Non-Current Assets (Quarter) stood at $5.2 million in 2021, then dropped by 12.53% to $4.5 million in 2023, then decreased by 16.16% to $3.8 million in 2024, then decreased by 23.02% to $2.9 million in 2025.
- Its last three reported values are $2.9 million in Q3 2025, $3.6 million for Q2 2025, and $3.0 million during Q1 2025.